Prognostic factors and risk models in myelodysplastic syndromes.


The myelodysplastic syndromes (MDS) encompass a hematologically diverse group of neoplastic disorders with a common pathological and clinical phenotype but distinct underlying biology and variable outcome. The prognosis of MDS depends on disease risk features, host factors, and their interaction. Risk stratification allows forecasting of disease prognosis… (More)
DOI: 10.1016/j.clml.2013.05.022


  • Presentations referencing similar topics